An amended Form 144/A was filed on November 10, 2026, disclosing a proposed sale of 1,234,964 common shares of Roivant Sciences Ltd. by Officer Frank M. Torti, with the transaction linked to a mandatory sell-to-cover arrangement for tax withholding on vested equity awards.
Key Highlights
- Filer and role: Frank M. Torti, an Officer of Roivant Sciences Ltd., is the person for whose account the securities are to be sold.
- Shares to be sold: 1,234,964 shares of Roivant Sciences Ltd. common stock, with an aggregate market value of $50,732,321.12 as stated in the filing.
- Shares outstanding: 724,561,460 common shares outstanding, according to the filing.
- Acquisition source: The shares were acquired on November 10, 2026, through Performance Stock Units from the Issuer, with payment described as "Services Rendered."
- Sell-to-cover purpose: The filing states the shares are being sold automatically pursuant to a mandatory, non-discretionary, sell-to-cover arrangement adopted by the Issuer to satisfy tax withholding obligations upon vesting and settlement of equity awards.
- Broker: Morgan Stanley Smith Barney LLC Executive Financial Services, 1 New York Plaza, 8th Floor, New York, NY 10004, is named as the broker.
- No prior sales: The filing reports nothing to report under securities sold during the past 3 months.
Roivant Sciences Officer Frank Torti Proposes Sale of Vested PSU Shares via Mandatory Tax Withholding Arrangement
According to the amended Form 144/A filing dated November 10, 2026, Frank M. Torti, identified as an Officer of Roivant Sciences Ltd. (NASDAQ:ROIV), disclosed a proposed sale of 1,234,964 common shares with an aggregate market value of $50,732,321.12. The filing states that 724,561,460 common shares were outstanding at the time of the notice, and the approximate date of sale is listed as November 10, 2026.
The filing discloses that the shares to be sold were acquired on November 10, 2026, through Performance Stock Units issued by the Issuer, with the nature of payment described as "Services Rendered." The filing notes no securities were sold during the prior three months by the reporting person.
As part of an amendment to the original filing (previous accession number 0001950047-26-010935), the following remark was added: "The Shares covered by this Form 144 are being sold automatically pursuant to a mandatory, non-discretionary, sell-to-cover arrangement adopted by the Issuer for the purpose of satisfying tax withholding obligations incurred upon the vesting and settlement of equity awards." The sale is not described as a discretionary transaction by the officer.
What Was Disclosed
Roivant Sciences Ltd. Officer Frank M. Torti filed an amended Form 144/A on November 10, 2026, proposing the sale of 1,234,964 common shares valued at $50,732,321.12, acquired through Performance Stock Units, to cover tax withholding obligations upon equity award vesting.



Please wait processing your request...